Heart Test Laboratories, Inc. (HSCS)

5.21 -0.09 (-1.70%) 收市：04:00PM EDT

Heart Test Laboratories, Inc.

550 Reserve Street
Suite 360
Southlake, TX 76092
United States
682 237 7781
https://heartsciences.com

版塊: Healthcare
行業: Medical Devices
全職員工: 12

高階主管

名稱	頭銜	支付	行使價	出生年份
Mr. Andrew Simpson	CEO, President & Chairman of the Board of Directors	264.14k	無	1970
Ms. Danielle Watson	CFO & Treasurer	188.75k	無	1983
Mr. Mark T. Hilz	COO, Secretary & Director	263.61k	無	1959

截止 2023年12月31日為止計算的金額，現金賠償則計算至上一個財政年度末止。薪資是指薪俸、獎金等。已行使價是指財政年度期間已行使的期權價值。貨幣為 USD。

描述

Heart Test Laboratories, Inc., doing business as HeartSciences, is a medical technology company focuses on applying AI-based technology to an ECG to expand and improve an ECG's clinical utility. It is developing AI-ECG solutions to be made available on a hardware agnostic cloud-based platform or its proprietary MyoVista wavECG device, to help identify cardiovascular disease in any care setting worldwide in a manner to suit different care providers. Its first product candidate for FDA clearance, the MyoVista wavECG, or the MyoVista, is a resting 12-lead ECG that is designed to provide diagnostic information related to cardiac dysfunction. The MyoVista also provides conventional ECG information in the same test. The company was incorporated in 2007 and is headquartered in Southlake, Texas.

公司管治

截至 無 止，Heart Test Laboratories, Inc. 的 ISS 管治質素評分為 無。 Pillar 分數正在審核中：無；董事會：無；股東權利：無；現金賠償：無。

企業管治評分的資料提供： Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險，而 10 分表示較高的管治風險。